Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Ruka Pharma Oy
OY
Dissolved
Y-tunnus 1793221-8
As. 26, 15140
Lahti
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2002
0 employees
Watchlist
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Ruka Pharma Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
EUR millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
EUR thousands
Item
2021
2022
2023
2024
2025
Revenue
11
11
11
7
7
Staff expenses
—
—
−0
−0
−0
EBITDA
6
6
5
2
2
Depreciation & amort.
—
—
−0
−0
−0
EBIT
6
6
5
2
2
Net financials
0
—
−3
0
0
Profit before tax
6
6
2
3
2
Tax
−1
1
1
1
0
Net profit
6
5
1
2
2
Balance sheet
EUR thousands
Item
2021
2022
2023
2024
2025
Total assets
222
208
192
180
180
Equity
220
207
192
178
180
Long-term debt
—
—
0
0
0
Short-term debt
2
0
0
2
0
Total debt
2
0
0
2
0
Financial ratios
5-year trend
EBITDA margin
21.6%
This company
15.8%
Market median
+37% vs market
2021
2025
Equity ratio
99.7%
This company
38.2%
Market median
+161% vs market
2021
2025
Return on equity
0.9%
This company
18.4%
Market median
-95% vs market
2021
2025
Net profit margin
20.9%
This company
8.1%
Market median
+158% vs market
2021
2025
Asset turnover
0.04×
This company
1.12×
Market median
-96% vs market
2021
2025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on Ruka Pharma Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
